First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapy.
Yanagisawa T, Kawada T, Bekku K, Laukhtina E, Rajwa P, von Deimling M, Chlosta M, Quhal F, Pradere B, Karakiewicz PI, Mori K, Kimura T, Shariat SF, Schmidinger M.
Yanagisawa T, et al. Among authors: mori k.
BJU Int. 2024 Apr 24. doi: 10.1111/bju.16336. Online ahead of print.
BJU Int. 2024.
PMID: 38659099
Review.